Select Publications
These selected publications showcase research that spans fundamental T-cell biology, cancer immunology, and cellular therapy. Together, they highlight efforts to define the genetic and immune mechanisms underlying cancer and immune-mediated disease, identify novel therapeutic targets, and translate discoveries in human T-cell biology into next-generation immunotherapies and engineered cellular therapies.
2025
Journal of Clinical Investigation - April 15
Addiction of primary cutaneous γδ T cell lymphomas to JAK/STAT signaling
Zhang, Y., Choi, J., et al. Journal of Clinical Investigation (2025). DOI: 10.1172/JCI180417
2024
Cancer Discovery - September 4
Reinstein, Z.Z., Choi, J., et al. Cancer Discovery (2024). DOI: 10.1158/2159-8290.CD-23-0798
Nature - February
Naturally occurring T cell mutations enhance engineered T cell therapies
Garcia, J., Choi, J., et al. Nature (2024). DOI: 10.1038/s41586-024-07627-2
Nature - July 10
Interferon subverts an AHR-JUN axis to promote CXCL13+ T cells in lupus
Law, C., Choi, J., et al. Nature (2024). DOI: 10.1038/s41586-024-07845-8
2023
Nature Immunology - October 16
Wartewig, T., Choi, J., et al. Nature Cancer (2023). DOI: 10.1038/s43018-023-00635-7
2021
Blood - October 7
Park, J., Choi, J., et al. Blood (2021). DOI: 10.1182/blood.2020009655
2020
Nature Communications - April 14
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas
Daniels, J., Choi, J., et al. Nature Communications (2020). DOI: 10.1038/s41467-020-15572-7